NovoCure Limited Analysis
| Analyst Ratings |
|
Average Target Price
|
99.25
|
|
Average Rating
|
3.13
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
2
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.24
|
0.00
|
0.24
|
100.00%
|
|
2022-12-31
|
-0.29
|
0.00
|
0.29
|
100.00%
|
|
2022-09-30
|
-0.26
|
-0.25
|
0.01
|
3.85%
|
|
2022-06-30
|
-0.14
|
-0.23
|
-0.09
|
-64.29%
|
|
2022-03-31
|
-0.18
|
-0.04
|
0.14
|
77.78%
|
|
2021-12-31
|
-0.10
|
-0.25
|
-0.15
|
-150.00%
|
|
2021-09-30
|
-0.07
|
-0.13
|
-0.06
|
-85.71%
|
|
2021-06-30
|
0.01
|
-0.14
|
-0.15
|
-1500.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.52
|
|
2021-12-31
|
-0.56
|
|
2020-12-31
|
0.19
|
|
2019-12-31
|
-0.08
|
|
2018-12-31
|
-0.70
|
|
2017-12-31
|
-0.70
|
|
2016-12-31
|
-1.55
|
|
2015-12-31
|
-3.17
|